Search

Search Constraints

You searched for: Author/Creator Scherl, Ellen J.

Search Results

2. A Quality Improvement Initiative Is Associated With Reduced Time to Administer Biologics and Small Molecules and Emergency Room Visits in Inflammatory Bowel Disease. Issue 3 (7th March 2022)

3. A Quality Improvement Initiative Is Associated With Reduced Time to Administer Biologics and Small Molecules and Emergency Room Visits in Inflammatory Bowel Disease. Issue 3 (March 2022)

4. A Quality Improvement Initiative to Reduce Insurance‐Related Delays in Patient Access to Biologic Therapies for Inflammatory Bowel Disease: 641. (October 2019)

9. Cost‐Effectiveness of Vedolizumab Compared to Adalimumab for Patients with Crohn's Disease After Loss of Response to Infliximab: A Markov Model: 749. (October 2016)

10. Debunking the Myth That Hepatosplenic T‐Cell Lymphoma Is Just a Disease of Young Males with Inflammatory Bowel Disease on Thiopurines: 1763. (October 2016)